ARQT is Arcutis Biotherapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $23.90. Market cap: $3.00B. Capital Quality Rank: 79/100 — Elite compounder.
Stock snapshot
| Price | $23.90 |
| Market cap | $3.00B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 79 / 100 · Elite compounder |
| ROIC (TTM) | -3.8% |
| Revenue CAGR (3y) | 367.3% |
| Shareholder buyback yield | -4.93% |
| Altman Z-score zone | Safe |
About ARQT
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Related non-dividend companies
Other non-dividend stocks investors research alongside ARQT. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ARQT's current stock price?
ARQT (Arcutis Biotherapeutics, Inc.) is currently trading at $23.90.
Does ARQT pay a dividend?
ARQT (Arcutis Biotherapeutics, Inc.) does not currently pay a regular dividend.
What is ARQT's Capital Quality Rank?
ARQT has a Capital Quality Rank of 79/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track ARQT in DiviDrip
Add ARQT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ARQT and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.